Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AEON and TON Host GameOn TON Global Gaming Hackathon Opening Ceremony in Singapore Featuring Esteemed Industry Leaders and Speakers
-
2024 Asia Triathlon Cup Wuhan Grandly Opened, Catching World's attention to the “River City” of Chu Culture
-
Murder Mystery on Fire Island Set to Captivate Audiences With Gripping Tale of Intrigue
-
RDK Adopted by Vodafone as Centralized Software Platform for Home Broadband Devices Across Europe
-
e.l.f. SKIN Is Salvation to Skincare Shame in Satirical “Divine Skintervention” Campaign
-
Event Industry Icon Joins Nvision360 as Senior Vice President of Business Development
-
HEARTWOOD PARTNERS INVESTS IN ROYAL PRODUCTS TO SUPPORT GROWTH
-
Trailhead Biosystems Announces Joshua Snow as Chief Commercial Officer
-
Urology of Virginia Men's Health VA division Hosts the Summit 2024!
-
Over 70 Full Sail University Alumni Credited on 76th Primetime Emmy-Winning Projects
-
Enabling Linux in Safety Applications (ELISA) Project Welcomes Hamburg University of Technology - Institute of Aircraft Systems Engineering and Lynx Software Technologies to Strengthen their Commitmen
-
15 game-changing projects on Tezos and Etherlink will showcase at Tezos Realm during TOKEN2049 week
-
Risen Energy Champions Environmental Stewardship for a Greener Future
-
Circle and Sony Block Solutions Labs to Enable USDC on Soneium to Empower a Creator Economy
-
Alvarez & Marsal Tax Expands Across Asia Pacific Hiring James Badenach as Managing Director to Lead New Regional Offering
-
Masimo Shares Final Thoughts Ahead of September 19 Annual Meeting Where Everything is at Stake
-
Vera Bradley Foundation for Breast Cancer Raises $1,601,830 for Breast Cancer Research
-
Pilbara Aboriginal artists share cultural stories for the 19th Colours of our Country exhibition
-
Stonepeak-backed MIDC Completes Combination with PhilTower
-
The Biggest Stars of Television Came out to Celebrate at the GBK & MEND Luxury Prime Time Television Awards Lounge
-
Ballin Injury Law Firm Achieves Industry Milestone; Reaches 10,000 Clients Served Throughout Boston and Massachusetts
-
Toden Announces Presale with 500X Potential: A New Community-Driven Meme Token
-
The Rise of AI Chatbots: Transforming Digital Interaction in The 21st Century
-
Politan Comments on Masimo’s Latest Attempt to Block a Fair Shareholder Vote
-
GlobalFinFocus Announces Innovative Automation and Outsourced Accounting Services for Businesses
-
TORL BioTherapeutics Presents Updated Phase 1 Results of Novel Claudin 6 Targeted Antibody-Drug Conjugate TORL-1-23 at the 2024 European Society of Medical Oncology Congress
-
Broadridge's Securities-based Lending Capabilities and Wealth Lending Network Now Integrated with Morningstar Advisor Workstation
-
Rexel: Rexel Board of Directors rejects an unsolicited preliminary proposal from QXO
-
MEXC First to Launch CATI Spot and Futures trading. Share a Prize Pool of 1,000,000 CATI and 80,000 USDT in Futures Bonuses!
-
IMPERIAL PETROLEUM INC. Declares Dividend on Series A Preferred Shares
-
JET (Satoshi Airline) Now Available to Trade on LBank Exchange
-
United Media Services Participates in Panel Discussion at the International Broadcasting Convention (IBC) in Amsterdam
-
AuMEGA Metals Extends Gold Mineralisation at Central Zone in Newfoundland
-
YTRanker Unveils Video Review Service to Build Rapid Social Proof on YouTube
-
World's 1st Flashlight Experience Store Kicks Off in Las Vegas
-
Master Roofing Inc. Strengthens Community Ties Through Local Engagement and Support
-
Eurasian Capital Announces Name Change to Eurasian Frontier Financial Capital to Propel Global Expansion Plans
-
Hero.io AI Innovations Take Center Stage at Token2049 Side Events
-
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as Single Agent After Surgery Reduced Risk of Death by More Than One-Third (34%) Versus Neoadjuvant Chemotherapy in High-Risk
-
IMFINZI® (durvalumab) perioperative regimen reduced the risk of recurrence by 32% and the risk of death by 25% vs. neoadjuvant chemotherapy alone in muscle-invasive bladder cancer in the NIAGARA Phas
-
ATA Celebrates America's Professional Truck Drivers During National Truck Driver Appreciation Week
-
Michael James of James Trial Law Proudly Accepts the Elite Lawyer Recognition for a Third Consecutive Years
-
Replimune Presents Primary Analysis Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at European Society for Medical Oncology (ESMO) Congress 2024
-
Alcoa Announces Agreement to Sell its 25.1% Stake in Ma’aden Joint Venture to Ma’aden
-
Gold IRA Pros and Cons: Expert Explanation
-
Precious Metals IRA: Accounts, Reviews, and Rules Explained by an Expert
-
Bristol Myers Squibb Presents Landmark 10-Year Follow-Up Data from CheckMate -067 Which Showed Continued Durable Long-Term Survival Benefit with Opdivo® plus Yervoy® in Advanced Melanoma
-
Scorpion Therapeutics Presents Initial Clinical Data From Its Phase 1/2 Trial of STX-478 Demonstrating Potentially Best-in-Class Mutant-Selective PI3Kα Inhibition for the Treatment of Advanced Solid
-
Ten-Year Data for Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Sustained Overall Survival Benefit Versus Ipilimumab in Advanced Melanoma
-
Exelixis Presents Final Overall Survival Results from Phase 3 CONTACT-02 Pivotal Study Evaluating Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Metastatic Castration-Resistant Pro
